Overview


According to FutureWise analysis the market for Finasteride in 2023 is US$ 0.11 billion, and is expected to reach US$ 0.12 billion by 2031 at a CAGR of 1.82%.

Finasteride is used as an active ingredient of drugs for the treatment of cancer and baldness in men. BPH symptoms are alleviated, urination is reduced, and urinating flow is improved with less pressure using these products. A major contributor to prostate development is natural body hormone (DHT), which is lowered by the active ingredient. Treatment with finasteride for benign prostatic hypertrophy (BPH) can be done alone or with another drug. Treatment with finasteride can reduce the risk of acute urinary retention, as well as regular and difficult urination symptoms associated with BPH. Additionally, it can reduce the likelihood of prostate surgery. Male pattern hair loss is the gradual thinning of the hair on the scalp, leading to a receding hairline or balding on the top of the head in men. Finasteride is used to treat this condition. There is no evidence that finasteride can treat thinning hair at the temples, and it cannot be used to treat hair loss in women or children. 5-alpha reductase inhibitors are a class of drugs that include finasteride. By preventing the body from producing a male hormone that causes the prostate to swell, finasteride treats BPH. By preventing the body from producing a male hormone in the scalp that inhibits hair growth, finasteride treats male pattern hair loss. The oral drug finasteride is used to treat benign prostate hyperplasia, which is caused by prostate enlargement in men. Men with benign prostate hyperplasia, which causes problems urinating, can take finasteride to treat their condition. Demand for finasteride is primarily driven by the ever-increasing number of prostate cancer cases. Another factor promoting market growth is customer preferences for hair treatment and spending on hair care products. With finasteride being increasingly used to treat hair loss and treating BPH as well as increasing urine flow, minimizing nighttime urination, and improving bladder control, the market for the product is growing. The Finasteride Market would be affected by increased patents, as well as regulations which protect the pharmaceutical industry. Government regulations promoting exclusive rights to market participants' goods will boost the Finasteride Market. As a result of raising awareness of hair loss issues, government organizations are constantly promoting the use of the chemical. Finasteride's demand for medical purposes is also likely to be supplemented by guidelines from medical institutes and physicians. Lockdown measures have been implemented in several countries as a result of the pandemic, which is expected to have a major impact on the global Finasteride Market. As a result of the Coronavirus, patient visits and treatment acceptance rates have decreased in the global Finasteride Market. Due to the shutdown, manufacturing activities have also been halted, restraining the growth of the global Finasteride Market. As a result of industry members' research and development efforts to address safety concerns, new opportunities would be created and the Finasteride Market would expand and grow.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Finasteride Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Finasteride Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  • Merck and Company
  • Novartis International AG
  • Teva Pharmaceuticals Limited
  • Dr Reddy’s
  • RelconChem Limited
  • Actavis Pharmaceutical Company
  • Cipla Ltd.
  • Accord Pharmaceuticals
  • Henan Topfond
  • Zhejiang CONBA Pharmaceutical
  • Guangdong Eashu Pharmaceutical
  • Shandong Renheteng Pharmaceutical
  • Veru Inc

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Drug Dose

  • 1 mg
  • 5 mg

By Application

  • Prostate Treatment
    • Prostate Enlargement
    • Prostate Cancer
    • Hormone Therapy
  • Hair Treatment
    • Scalp Hair Loss
    • Excessive Hair Growth

By Distribution Channel

  • Institutional Sales
    • Hospitals
    • Speciality Clinics
    • Research Institutes
  • Retail Sales
    • Retail Pharmacies
    • Online Pharmacies

By Region

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Finasteride Market By Drug Dose, By Application, By Distribution Channel and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

 

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Finasteride Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Finasteride Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Finasteride Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Finasteride Market, By Drug Dose Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. 1 mg
        2. 5 mg

  • 8.   Finasteride Market, By Application, Historical Analysis and Forecast 2023-2031 (USD Million)
    •         1. Prostate Treatment
                 1.1. Prostate Enlargement
                 1.2. Prostate Cancer
                 1.3. Hormone Therapy
              2. Hair Treatment
                 2.1. Scalp Hair Loss
                 2.2. Excessive Hair Growth

  • 9.   Finasteride Market, By Distribution Channel Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Institutional Sales
         1.1. Hospitals
         1.2. Speciality Clinics
         1.3. Research Institutes
        2. Retail Sales
         2.1. Retail Pharmacies
         2.2. Online Pharmacies

  • 10.   North America Finasteride Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.   Latin America Finasteride Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.   Europe Finasteride Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.   Asia Pacific Finasteride Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.   Middle East and Africa Finasteride Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Merck and Company
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Novartis International AG
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Teva Pharmaceuticals Limited
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Dr Reddy’s
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. RelconChem Limited
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Actavis Pharmaceutical Company
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Cipla Ltd.
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Accord Pharmaceuticals
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Henan Topfond
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Zhejiang CONBA Pharmaceutical
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. Guangdong Eashu Pharmaceutical
         11.1. Company Overview
         11.2. Product Portfolio
            11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12. Shandong Renheteng Pharmaceutical
         12.1. Company Overview
           12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
        13.Veru Inc
         13.1. Company Overview
         13.2. Product Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the regulations initiated by healthcare administrations
        5. The overall economic slowdown of the developing and developed nations
  • 18.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients